EverFlex Post Approval Study

Completed · Not applicable

Conditions studied: Peripheral Arterial Disease, Lower Extremity Arterial Disease

In brief

This post-approval study is designed to confirm the long-term safety and effectiveness of the EverFlex™ Self-Expanding Stent System for the treatment of atherosclerotic superficial femoral artery (SFA) and proximal popliteal arteries.

Key facts

Study ID
NCT01680835
Run by
Medtronic Endovascular
People needed
108
Starts
2013-01-14
Expected to finish
2019-02-04
Last updated by the study team
2019-12-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.